3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
46
Lymphoma, Mantle-Cell
20
Lymphoma, Follicular
13
Waldenstrom Macroglobulinemia
12
Lymphoma, Non-Hodgkin
12
Lymphoma, Large B-Cell, Diffuse
12
Lymphoma
11
Lymphoma, B-Cell
10
Leukemia
9
Recurrence
8
Multiple Myeloma
5
Lymphoma, B-Cell, Marginal Zone
5
Leukemia, Lymphoid
4
Leukemia, B-Cell
4
Hodgkin Disease
4
Bronchiolitis Obliterans Syndrome
4
Hematologic Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms, Plasma Cell
2
Neoplasms
2
Lung Neoplasms
2
Leukemia, Prolymphocytic
2
Leukemia, Myeloid, Acute
2
Graft vs Host Disease
2
Chromosome 17 deletion
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Burkitt Lymphoma
2
Squamous Cell Carcinoma of Head and Neck
1
Smoldering Multiple Myeloma
1
Interventions
Rituximab
4
blinatumomab
3
Whole-Body Irradiation
3
Cyclophosphamide
3
fludarabine phosphate
2
Mycophenolic Acid
2
Melphalan
2
Lenalidomide
2
Clofarabine
2
treosulfan
1
thymoglobulin
1
sabatolimab
1
pembrolizumab
1
peginterferon alfa-2a
1
obinutuzumab
1
midostaurin
1
ixazomib
1
fludarabine
1
eribulin
1
daratumumab
1
acalabrutinib
1
Trastuzumab
1
Tacrolimus
1
Sodium Chloride
1
Sirolimus
1
Peripheral Blood Stem Cell Transplantation
1
Pentostatin
1
N,N-dicyclohexyl-isoborneol-10-sulfonamide
1
Methotrexate
1
Magnetic Resonance Imaging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neoplasm, Residual
×
ibrutinib
×
Clear all
No trials found.